IBI Ag Bags $6.1 Million in Series A Funding
IBI Ag, a crop protection startup developing a wide array of bio-insecticides with a lower ecological footprint, announced it has successfully closed the first part … Read more…
IBI Ag, a crop protection startup developing a wide array of bio-insecticides with a lower ecological footprint, announced it has successfully closed the first part … Read more…
Bioxodes, a clinical stage biopharmaceutical company developing novel therapies for the prevention and treatment of thrombotic and inflammatory diseases, raised €2.7 million from existing investors … Read more…
Tidal Vision, a biotechnology company transforming critical industries with chitosan-based chemistries, announced the closing of an oversubscribed $140 million Series B financing round. The funding … Read more…
Orbis Medicines, a Denmark-based oral macrocycle drug discovery company, raised €90 million in Series A funding. New Enterprise Associates (NEA) led the investment round with … Read more…
General Proximity, a seed-stage biotechnology company, raised $16 million in seed funding to accelerate the development of treatments targeting undruggable proteins associated with cancer, cardiometabolic disease, neurodegeneration, … Read more…